| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_52fe1996c762a50492c26af80c83da28 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-737
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-726
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-726 |
| filingDate |
2013-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba5d42193ba82e75810340ecde84d96c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92c6db8ea5d83afa2fdfb29699d0def7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c01f8ac1872b93c2f4ba51d4a8be138d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5eba8c545ebcc26f5e37a287d47787ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd8af02a7c193167883fb77b4e6a532b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44ebef8104db5ef8c6a83a02b13d27b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aacf7f3261be62cff9a856300b4f5c2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efbd6623a44c68e458b722c184a3985c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed8d4eda05550d88f55c85354050a376 |
| publicationDate |
2015-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2015152198-A1 |
| titleOfInvention |
Low-Molecular-Weight Biotechnological Chondroitin 6-Sulphate for Prevention of Osteoarthritis |
| abstract |
Disclosed is a low-molecular-weight (1000-5000 daltons) chondroitin sulphate (CS) produced by chemical sulphation and subsequent depolymerisation of a non-sulphated chondroitin backbone obtained with biotechnology techniques. The CS described is substantially monosulphated, mainly at the 6-position, with very little sulphation at the 4-position, and with a mono/disulphated disaccharide ratio and charge density similar to those of natural CS. Said biotechnological chondroitin 6-sulphate (C6S) is useful in the treatment and prevention of osteoarthritis and in acute and chronic inflammatory processes. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11572421-B2 |
| priorityDate |
2012-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |